Latest filing published 04 Feb 2019 for Opus Genetics, Inc., €5,554.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -71.6%Entry US$29.28 · Close at T+365 US$8.32
- -71.2%Entry US$1,152.00 · Close at T+365 US$331.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Charles Beever: trading record in brief
Charles Beever is a declared insider of Opus Genetics, Inc., with filings sourced from SEC (Form 4). Between 8 April 2008 and 31 January 2019, the trades on record add up to 10 filings.
Every open-market trade on record is a purchase: 10 purchases worth €21k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2019: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €1,185. After 10 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -54.2%. These figures describe past trades and do not predict future prices.
Most recently, on 4 February 2019, the filings show an open-market purchase worth €5,554 in Opus Genetics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles Beever
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.638100.0% of flowCommon StockSEC:0001140361-19-002419:0Canonical exit: 1 May 2019 (T+90)
- 1,000 shares@ US$2.50Common StockSEC:0001140361-08-009286:0Canonical exit: 7 Jul 2008 (T+90)
- 3,362 shares@ US$2.50Common StockSEC:0001140361-08-009286:1Canonical exit: 7 Jul 2008 (T+90)
- 500 shares@ US$2.50Common StockSEC:0001140361-08-009286:2Canonical exit: 7 Jul 2008 (T+90)
- 1,960 shares@ US$2.50Common StockSEC:0001140361-08-009286:3Canonical exit: 7 Jul 2008 (T+90)
- 500 shares@ US$2.49Common StockSEC:0001140361-08-009286:4Canonical exit: 7 Jul 2008 (T+90)
- 1,178 shares@ US$2.40Common StockSEC:0001140361-08-009286:5Canonical exit: 7 Jul 2008 (T+90)
- 500 shares@ US$2.35Common StockSEC:0001140361-08-009286:6Canonical exit: 7 Jul 2008 (T+90)
- 500 shares@ US$2.30Common StockSEC:0001140361-08-009286:7Canonical exit: 7 Jul 2008 (T+90)
- 500 shares@ US$2.25Common StockSEC:0001140361-08-009286:8Canonical exit: 7 Jul 2008 (T+90)
10 of 10 declarations